A Rare Case of Kounis Syndrome Secondary to Infliximab.

Cureus

Interventional Cardiology, Veteran Affairs (VA) Caribbean Healthcare System, San Juan, PRI.

Published: September 2023

Kounis syndrome (KS) is an acute coronary syndrome triggered by allergic or anaphylactic reactions. It manifests as coronary artery vasospasm, acute myocardial infarction, or coronary stent thrombosis, resulting from inflammatory cytokine release and inappropriate activation of platelets and mast cells. We present a case of an 85-year-old male with Crohn's disease who suffered anaphylaxis during infliximab infusion, culminating in non-ST myocardial infarction (NSTEMI). The patient's symptoms were effectively managed with epinephrine and diphenhydramine, and KS secondary to infliximab was diagnosed. Diagnosing KS can be challenging due to the overlapping signs of an allergic reaction and myocardial infarction. Timely recognition and appropriate management of KS are crucial to enhance patient outcomes. Therefore, healthcare providers should maintain a high index of suspicion for KS in patients with acute coronary syndromes linked to allergic reactions to optimize care and minimize potential risks. This case report underscores the significance of prompt intervention and awareness of Kounis syndrome in clinical practice.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557359PMC
http://dx.doi.org/10.7759/cureus.44704DOI Listing

Publication Analysis

Top Keywords

kounis syndrome
12
myocardial infarction
12
secondary infliximab
8
acute coronary
8
rare case
4
case kounis
4
syndrome
4
syndrome secondary
4
infliximab kounis
4
syndrome acute
4

Similar Publications

Kounis Syndrome Following a Wasp Sting.

Am J Forensic Med Pathol

January 2025

From the Department of Forensic Medicine, University of Pretoria, Prinshof Campus, Pretoria, South Africa.

View Article and Find Full Text PDF

To study a case of Kounis syndrome (KS) type II, characterized by allergy, myocardial infarction, and ventricular fibrillation. A patient diagnosed with KS type II was admitted to Yangpu Hospital, School of Medicine, Tongji University in 2021. After systemic treatment, routine investigations, including blood tests, electrocardiography (ECG), and biochemical and coagulation analyses, were performed.

View Article and Find Full Text PDF

Kounis Syndrome Following Moxifloxacin and Deflazacort Administration.

Eur J Case Rep Intern Med

December 2024

Emergency Department, Ente Ospedaliero Cantonale - Ospedale Regionale di Lugano, Lugano, Switzerland.

Unlabelled: Kounis syndrome (KS), characterized by the simultaneous occurrence of acute coronary syndrome (ACS) and allergic reactions, can be triggered by a range of factors and drugs. We report on the case of a patient who arrived at our emergency department (ED) with symptoms of an allergic reaction after taking moxifloxacin and deflazacort orally. In the ED, the patient experienced a 5-minute episode of oppressive chest pain.

View Article and Find Full Text PDF

Kounis syndrome following COVID-19 vaccination: Clinical manifestations, mechanisms and management.

Hum Vaccin Immunother

December 2024

Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China.

Article Synopsis
  • Kounis syndrome is an acute coronary condition triggered by allergic reactions, resulting in heart damage and, in some cases, anaphylactic shock.
  • This syndrome can occur as a rare side effect of COVID-19 vaccinations, highlighting the need for further case studies to improve understanding and treatments.
  • Analysis of data from 15 patients revealed that the first vaccine dose is more likely to cause Kounis syndrome, emphasizing the importance of prompt diagnosis and monitoring for cardiac symptoms after vaccination.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!